1
|
Peng G, Hou X, Zhang W, Song M, Yin M, Wang J, Li J, Liu Y, Zhang Y, Zhou W, Li X, Li G. Alkyl rhamnosides, a series of amphiphilic materials exerting broad-spectrum anti-biofilm activity against pathogenic bacteria via multiple mechanisms. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY 2019; 46:S217-S232. [PMID: 30618296 DOI: 10.1080/21691401.2018.1491474] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
As novel amphiphilic materials, six uncharged alkyl rhamnosides incorporating various alkyl chain and one rhamnose amine quaternary ammonium salt were successfully synthesized in this study. Their amphiphilic properties (HLB and CMC), antimicrobial and anti-biofilm activity against S. aureus and P. aeruginosa were investigated. Differentially regulated proteins and pathways were identified by comparative proteomics research to first give a sight on how alkyl rhamnosides performed the anti-biofilm activity at protein and pathway levels. Among the uncharged alkyl rhamnosides, dodecyl rhamnoside and octyl rhamnoside showed the best antimicrobial and anti-biofilm ability against S. aureus and against P. aeruginosa, respectively. Interestingly, the relationships between amphiphilic properties or MIC with anti-biofilm activity were first established. Uncharged alkyl rhamnoside with an optimized HLB value of 5.0 had both the strongest antibacterial and anti-biofilm activity against S. aureus, and MIC was the maximum biofilm inhibitory concentration for all alkyl rhamnosides. Alkyl rhamnosides have a significant overall regulatory effect on the proteomics and pathways of bacterial biofilms, including energy production, substrates transportation, signal transduction, key molecules balance, and so on. These amphiphilic materials have a great potential to be used as additives in pharmaceutic, cosmetic, food industry, hospital and in other non-medical fields.
Collapse
Affiliation(s)
- Guanghua Peng
- a Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, School of Pharmaceutical Sciences , Peking University Health Science Center , Beijing , China
| | - Xucheng Hou
- a Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, School of Pharmaceutical Sciences , Peking University Health Science Center , Beijing , China
| | - Wenxi Zhang
- a Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, School of Pharmaceutical Sciences , Peking University Health Science Center , Beijing , China
| | - Maoyuan Song
- a Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, School of Pharmaceutical Sciences , Peking University Health Science Center , Beijing , China
| | - Mengya Yin
- a Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, School of Pharmaceutical Sciences , Peking University Health Science Center , Beijing , China
| | - Jiaxing Wang
- a Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, School of Pharmaceutical Sciences , Peking University Health Science Center , Beijing , China
| | - Jiajia Li
- a Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, School of Pharmaceutical Sciences , Peking University Health Science Center , Beijing , China
| | - Yajie Liu
- a Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, School of Pharmaceutical Sciences , Peking University Health Science Center , Beijing , China
| | - Yuanyuan Zhang
- a Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, School of Pharmaceutical Sciences , Peking University Health Science Center , Beijing , China
| | - Wenkai Zhou
- b Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College , Beijing , China
| | - Xinru Li
- a Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, School of Pharmaceutical Sciences , Peking University Health Science Center , Beijing , China
| | - Guiling Li
- b Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College , Beijing , China
| |
Collapse
|
2
|
Villadsen K, Martos-Maldonado MC, Jensen KJ, Thygesen MB. Chemoselective Reactions for the Synthesis of Glycoconjugates from Unprotected Carbohydrates. Chembiochem 2017; 18:574-612. [DOI: 10.1002/cbic.201600582] [Citation(s) in RCA: 59] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2016] [Indexed: 12/27/2022]
Affiliation(s)
- Klaus Villadsen
- Department of Chemistry; University of Copenhagen; Faculty of Science; Thorvaldsensvej 40 1871 Frederiksberg C Denmark
| | - Manuel C. Martos-Maldonado
- Department of Chemistry; University of Copenhagen; Faculty of Science; Thorvaldsensvej 40 1871 Frederiksberg C Denmark
| | - Knud J. Jensen
- Department of Chemistry; University of Copenhagen; Faculty of Science; Thorvaldsensvej 40 1871 Frederiksberg C Denmark
| | - Mikkel B. Thygesen
- Department of Chemistry; University of Copenhagen; Faculty of Science; Thorvaldsensvej 40 1871 Frederiksberg C Denmark
| |
Collapse
|